Julien L. Pham, MD, MPH, is the Founder and Managing Partner of 3CC | Third Culture Capital. See contact routes.
Julien L. Pham, MD, MPH, is the Founder and Managing Partner of 3CC | Third Culture Capital, a Boston-based seed-stage venture fund he launched in 2020 after serving as President & COO at biotech firm Genprex and co-founding the acquired digital health platform RubiconMD. His investment thesis targets seed-stage companies at the intersection of healthcare, AI, and health equity, specifically backing “unconventional” or “Third Culture” founders who are often overlooked by traditional capital. The firm has invested in 15 companies since 2021, with 11 squarely in digital health across sectors like mental and maternal health, though specific check sizes and lead/follow behavior are not publicly detailed. Notable portfolio companies include RubiconMD, which was acquired by Oak Street Health/CVS for $190M, and Genprex, a NASDAQ-listed gene therapy company where Pham led the IPO. Pham distinguishes his approach by leveraging his background as a child of Vietnamese refugees and a “Third Culture Kid” to support founders with unique cultural journeys, arguing these perspectives drive entrepreneurial success. He has publicly articulated this point of view in interviews
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Julien L. Pham · Full investor directory · Investor access · Company funding database